In samples pretreated with HPMC + β-CD (Figure 2A,B), Solution 1, an increase in GFP expression can be observed (about 3.5% vs. control, p < 0.05), leading to a reduction of about 34% cell viability compared to the infected control (p < 0.05), probably due to both pretreatment and infection (Figure 2C). The gene discussed is CYP4V2; the disease is infection.